Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer

ObjectiveTo compare effects and adverse events of anti-programmed cell death protein 1 (anti-PD-1) antibody combined with chemoradiotherapy (CRT) and CRT alone as the initial treatment in locally advanced esophageal squamous cell carcinoma (ESCC).MethodsWe retrospectively reviewed locally advanced E...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Ji Ma, Nan Yao, Jiaying Lu, Wanxi Qu, Li Cui, Shiwang Yuan, Na Li, Shaodong Tong, Zhaohui Qin, Yuanhu Yao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Subjects:	anti-PD-1 antibodies chemoradiotherapy esophageal squamous cell carcinoma progression-free survival (PFS) overall survival (OS)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1005856/full